Table 2.

Proposed ethical guidelines for clinical innovation in psychopharmacology

1	Use of a treatment based on a viable hypothesis, with a plausible biological, empirical, or theoretical basis
2	Intention to report one's experience for the scrutiny and benefit of the scientific community
3	Willingness to report unexpected observations, perhaps initially noted without an a priori hypothesis.
4	Acceptance of a uniquely high standard of informed consent, not simply for medico-legal purposes, but on ethical grounds